• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Sionna Therapeutics, Inc. - Common Stock (NQ:SION)

    36.87 -2.72 (-6.87%)
    Streaming Delayed Price Updated: 3:33 PM EDT, Apr 29, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 193,957
    Open 39.01
    Bid (Size) 36.81 (300)
    Ask (Size) 37.09 (300)
    Prev. Close 39.59
    Today's Range 36.50 - 40.30
    52wk Range 10.96 - 46.46
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Sionna Insider Sells $2.5 Million in Stock Amid 215% Surge, but Here's What Investors Should Watch ↗
    This biotech innovator in cystic fibrosis therapies reported a notable insider sale amid a year of standout stock performance. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Sionna Therapeutics Completes Enrollment in PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, Added to Standard of Care in Participants with Cystic Fibrosis
    Topline data is on track for anticipated readout in the summer of 2026 
    From Sionna Therapeutics, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -6.0%
    -6.0%
    1 Month
    +0.6%
    +0.6%
    3 Month
    -15.0%
    -15.0%
    6 Month
    -6.5%
    -6.5%
    1 Year
    +206.2%
    +206.2%

    More News

    Read More
    News headline image
    Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium
    From Sionna Therapeutics, Inc.
    Via GlobeNewswire
    Sionna Short Squeeze Fades As Raymond James Backs Cystic Fibrosis Breakthrough, RBC Warns Treatments Set High Bar ↗
    Via Stocktwits
    News headline image
    Sionna Chief Legal Officer Cashed Out Her Shares. Her Options Are Another Story ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    ENAVATE's Zenas Bio Pharma add Is a Footnote — The Obexelimab Pipeline Is What to Watch ↗
    Via The Motley Fool
    News headline image
    Sionna Stock Is Up 144% This Past Year. Is the Biotech a Buy as One Fund Makes a $7 Million Bet? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares ↗
    Via The Motley Fool
    News headline image
    Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
    From Sionna Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Sionna Therapeutics to Participate in Upcoming March 2026 Investor Conferences
    From Sionna Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Sionna Therapeutics to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026
    From Sionna Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Sionna Therapeutics Chief Legal Officer Caps Off Strong 2025 with Sale of Over 10,000 Shares ↗
    Via The Motley Fool
    Topics Initial Public Offering Regulatory Compliance
    News headline image
    Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From Sionna Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    A Sionna Therapeutics (SION) Insider Sold 33,000 Shares for $1.5 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Sionna Therapeutics to Participate in Upcoming December Investor Conferences
    From Sionna Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Sionna Therapeutics Reports Third Quarter 2025 Financial Results
    From Sionna Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Sionna Therapeutics to Participate in Upcoming November Investor Conferences
    From Sionna Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Monday's After-Market Session ↗
    Via Benzinga
    News headline image
    Sionna Therapeutics Announces Presentation of SION-719 and SION-451 Phase 1 Data and Poster of New Preclinical Data on the Impact of NBD1 Stabilizers on F508del-CFTR Half-Life at the 2025 North American Cystic Fibrosis Conference
    From Sionna Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Sionna Therapeutics Announces Initiation of PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, When Added to Standard of Care in Participants with Cystic Fibrosis
    From Sionna Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Sionna Therapeutics to Present Data at the 2025 North American Cystic Fibrosis Conference
    From Sionna Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Sionna Therapeutics Appoints Caroline Stark Beer as Chief Business Officer
    From Sionna Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Sionna Therapeutics Reports Second Quarter 2025 Financial Results
    From Sionna Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Hut 8, Greenbrier And Other Big Stocks Moving Higher On Tuesday ↗
    Via Benzinga

    Frequently Asked Questions

    Is Sionna Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Sionna Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Sionna Therapeutics, Inc. - Common Stock trade on?
    Sionna Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Sionna Therapeutics, Inc. - Common Stock?
    The ticker symbol for Sionna Therapeutics, Inc. - Common Stock is SION on the Nasdaq Stock Market
    What is the current price of Sionna Therapeutics, Inc. - Common Stock?
    The current price of Sionna Therapeutics, Inc. - Common Stock is 36.87
    When was Sionna Therapeutics, Inc. - Common Stock last traded?
    The last trade of Sionna Therapeutics, Inc. - Common Stock was at 04/29/26 03:33 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.